PACS Group (NYSE:PACS) Stock: Insider Jason Hulse Murray Sells 232 Shares

PACS Group, Inc. (NYSE:PACS) CEO Jason Murray sold 232 shares of PACS Group stock in a transaction dated Wednesday, October 14th. The shares were sold at an average price of $45.00, for a total value of $10,440.00. Following the completion of the transaction, the chief executive officer owned 54,435,017 shares in the company, valued at $2,449,575,765. This trade represents a 0.00% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Jason Hulse Murray also recently made the following trade(s):

• On Friday, October 16th, Jason Murray sold 8,462 shares of PACS Group stock. The stock was sold at an average price of $47.61, for a total transaction of $402,875.82.
• On Thursday, October 15th, Jason Murray sold 110,035 shares of PACS Group stock. The shares were sold at an average price of $47.27, for a total transaction of $5,201,354.45.
• On Wednesday, October 7th, Jason Murray sold 717 shares of PACS Group stock. The shares were sold at an average price of $42.48, for a total transaction of $30,458.16.
• On Tuesday, October 6th, Jason Murray sold 35,975 shares of PACS Group stock. The shares were sold at an average price of $43.09, for a total transaction of $1,550,162.75.
• On Monday, October 5th, Jason Murray sold 24,224 shares of PACS Group stock. The stock was sold at an average price of $42.66, for a total transaction of $1,033,395.84.
• On Friday, October 2nd, Jason Murray sold 26,052 shares of PACS Group stock. The stock was sold at an average price of $42.51, for a total transaction of $1,107,470.52.
• On Thursday, October 1st, Jason Murray sold 33,032 shares of PACS Group stock. The stock was sold at an average price of $41.13, for a total transaction of $1,358,606.16.
• On Monday, September 14th, Jason Murray sold 317 shares of PACS Group stock. The shares were sold at an average price of $45.03, for a total transaction of $14,274.51.
• On Friday, September 11th, Jason Murray sold 10,529 shares of PACS Group stock. The shares were sold at an average price of $45.23, for a total transaction of $476,226.67.
• On Thursday, September 10th, Jason Murray sold 8,771 shares of PACS Group stock. The shares were sold at an average price of $45.16, for a total transaction of $396,098.36.

PACS Group Stock Down 1.7%

PACS traded down $0.82 during trading on Friday, hitting $46.93. The stock had a trading volume of 958,006 shares, compared to its average volume of 895,386. The stock has a 50 day simple moving average of $43.61 and a two-hundred day simple moving average of $40.37. The company has a debt-to-equity ratio of 0.21, a quick ratio of 0.91 and a current ratio of 0.91. PACS Group, Inc. has a twelve month low of $10.31 and a twelve month high of $49.49. The company has a market capitalization of $7.43 billion, a PE ratio of 27.28, a PEG ratio of 1.40 and a beta of -0.08.

PACS Group (NYSE:PACS) last issued its quarterly earnings results on Tuesday, August 4th. The company reported $0.63 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.54 by $0.09. The business had revenue of $1.43 billion for the quarter, compared to the consensus estimate of $1.41 billion. PACS Group had a return on equity of 29.55% and a net margin of 4.85%. On average, research analysts predict that PACS Group, Inc. will post 2.13 earnings per share for the current year.

Analyst Ratings Changes

PACS has been the topic of several research analyst reports. Royal Bank Of Canada boosted their target price on PACS Group from $52.00 to $57.00 and gave the stock an “outperform” rating in a research note on Thursday, August 6th. Truist Financial set a $62.00 price target on PACS Group in a report on Wednesday, September 2nd. Weiss Ratings upgraded PACS Group from a “hold (c)” rating to a “hold (c+)” rating in a research note on Thursday, October 8th. UBS Group upped their price objective on shares of PACS Group from $57.00 to $60.00 and gave the company a “buy” rating in a report on Thursday, August 6th. Finally, Zacks Research lowered shares of PACS Group from a “strong-buy” rating to a “hold” rating in a research report on Wednesday, September 9th. Five research analysts have rated the stock with a Buy rating and two have issued a Hold rating to the company. According to data from MarketBeat.com, PACS Group currently has a consensus rating of “Moderate Buy” and an average price target of $58.80.

Institutional Investors Weigh In On PACS Group

A number of large investors have recently made changes to their positions in PACS. Dimensional Fund Advisors LP increased its position in shares of PACS Group by 370.2% in the 1st quarter. Dimensional Fund Advisors LP now owns 780,159 shares of the company’s stock valued at $25,051,000 after acquiring an additional 614,250 shares during the period. BI Asset Management Fondsmaeglerselskab A S purchased a new position in PACS Group in the 1st quarter worth $6,762,000. Bank of New York Mellon Corp purchased a new position in PACS Group in the 2nd quarter worth $8,196,000. Principal Financial Group Inc. acquired a new stake in PACS Group during the 1st quarter worth about $3,171,000. Finally, Arrowstreet Capital Limited Partnership lifted its position in PACS Group by 44.6% during the 1st quarter. Arrowstreet Capital Limited Partnership now owns 288,718 shares of the company’s stock worth $9,274,000 after acquiring an additional 89,067 shares during the period.

PACS Group Company Profile

PACS Group, Inc is a healthcare services company that operates skilled nursing and other post-acute care facilities in the United States. Its facilities provide services for patients who require medical care, rehabilitation, recovery support, or assistance with daily activities following hospitalization or other acute health events.

The company’s services generally include skilled nursing, physical and occupational therapy, speech therapy, long-term care, short-term rehabilitation, and other specialized post-acute programs.